Evidence map›Paper›PMID 15004508›Full record

ReviewApoptosis : an international journal on programmed cell death2004

The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodeling.

B McLaughlin

Open access · greenAbstract readReview
In one paragraph

Review in Apoptosis : an international journal on programmed cell death, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Fas-associated factor 1 as a regulator of olfactory axon guidance.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  14. Pathological accumulation of atrophin-1 in dentatorubralpallidoluysian atrophy.International journal of clinical and experimental pathology · 2011
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

B McLaughlinDepartment of Pharmacology, Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, TN 37232-8548, USA. bethann.mclaughlin@vanderbilt.edu
Vanderbilt University · US

Funding

THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
Cellular Mechanisms of Preconditioning NeuroprotectionR01NS050396 · NINDS · VANDERBILT UNIVERSITY · PI MCLAUGHLIN, BETHANN M · 2005 to 2009
$1.7M
NICHD NIH HHS P30 HD015052NICHD NIH HHS P30HD15052NINDS NIH HHS R01 NS050396
6 · The paper itself

Abstract

Caspases are a family of cysteine proteases that are expressed as inactive zymogens and undergo proteolytic maturation in a sequential manner in which initiator caspases cleave and activate the effector caspases 3, 6 and 7. Effector caspases cleave structural proteins, signaling molecules, DNA repair enzymes and proteins which inhibit apoptosis. Activation of effector, or executioner, caspases has historically been viewed as a terminal event in the process of programmed cell death. Emerging evidence now suggests a broader role for activated caspases in cellular maturation, differentiation and other non-lethal events. The importance of activated caspases in normal cell development and signaling has recently been extended to the CNS where these proteases have been shown to contribute to axon guidance, synaptic plasticity and neuroprotection. This review will focus on the adaptive roles activated caspases in maintaining viability, the mechanisms by which caspases are held in check so as not produce apoptotic cell death and the ramifications of these observations in the treatment of neurological disorders.

Indexed as

AnimalsBrainBrain IschemiaCalpainCaspase InhibitorsCaspasesCentral Nervous SystemEnzyme InhibitorsHumansNervous System DiseasesProteasome Endopeptidase ComplexCalpainCaspase InhibitorsCaspasesEnzyme InhibitorsProteasome Endopeptidase Complex

Identifiers

PMID15004508
PMCPMC2879070
OpenAlexW2006999333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.